EUVIMEDEUVIMED entdecken
Crossref

Serum Galectin‐1 and Galectin‐3 Levels and Their Relationship With Executive Functions and Memory in Patients With Major Depressive Disorder

Büşra Sultan Sevindik iD, Özlem Olguner Eker iD, Akif Asdemir iD, Esra Kısacık iD, Ayşe Işık iD, Eser Kılıç iD, Ertuğrul Eşel iD

Human Psychopharmacology: Clinical and Experimental · 2026-07 · 41 (4)

DOI: 10.1002/hup.70052 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Psychopharmacology: Clinical and Experimental, online erschienen am 18.06.2026. Verfasst von Büşra Sultan Sevindik und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Erciyes University Faculty of Medicine, Kayseri, Turkey. Hauptthemen laut MEDLINE: Major Depressive Disorder, Galectin 1, Executive Function, Galectin 3. Die Arbeit nennt 49 Literaturangaben. Gefördert von: The Scientific Research Project Unit of Erciyes University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Neuroinflammation is increasingly recognized as a key mechanism in the pathophysiology of Major Depressive Disorder (MDD). Galectin‐1 and Galectin‐3, β ‐galactoside‐binding lectins involved in immune regulation and neuroprotection, may serve as biomarkers linking inflammation to cognitive dysfunction. However, no previous study has simultaneously examined serum levels of these galectins alongside detailed cognitive assessments in MDD. This study aimed to determine whether Galectin‐1 and Galectin‐3 are altered in MDD and to explore their association with disease severity and cognitive performance.

Method

Forty patients with MDD and 40 matched healthy controls were assessed. Depressive and anxiety symptoms were measured using the Hamilton Depression (HAM‐D) and Anxiety (HAM‐A) Rating Scales. Cognitive performance was evaluated with the Rey Auditory Verbal Learning Test, Go/No‐Go Test, and Stroop Test. Serum Galectin‐1, Galectin‐3, Glomerular Filtration Rate (GFR), and C‐reactive protein (CRP) levels were determined.

Results

Serum Galectin‐1 and Galectin‐3 levels were significantly lower in the MDD group compared to controls ( p < 0.05). Galectin‐1 levels showed a negative correlation with HAM‐D and HAM‐A scores, indicating an inverse association with symptom severity (i.e., lower Galectin‐1 levels were associated with higher symptom severity). Patients exhibited impaired verbal learning, while no significant group differences were found in Go/No‐Go or Stroop performance. Galectin levels did not correlate with any cognitive test scores.

Conclusion

Reduced Galectin‐1 and Galectin‐3 levels in MDD support their involvement in neuroinflammatory mechanisms. The inverse association between Galectin‐1 and symptom severity suggests that Galectin‐1 may be associated with symptom severity; however, the direction of this relationship remains unclear. The lack of associations with cognitive performance implies that cognitive deficits in MDD may be mediated by other immunometabolic pathways. These findings highlight galectins as promising but complex biomarkers, warranting further investigation in larger and longitudinal studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Major Depressive DisorderGalectin 1Executive FunctionGalectin 3MemoryHumansMaleFemaleAdultBiomarkersMiddle AgedCase-Control StudiesSeverity of Illness IndexNeuropsychological TestsGalectinsBlood Proteins

Stichwörter der Autor:innen

cognitive functionsexecutive functionsgalectininflammationmajor depressive disordermemory

Substanzen

Galectin 1Galectin 3BiomarkersLGALS1 protein, humanLGALS3 protein, humanGalectinsBlood Proteins

Autor:innen und Institutionen

  • Department of Psychiatry, Erciyes University Faculty of Medicine, Kayseri, Turkey.
  • Department of Psychology, Nuh Naci Yazgan University, Kayseri, Turkey.
  • Department of Medical Biochemistry, Erciyes University Faculty of Medicine, Kayseri, Turkey.

ORCID-Profile: Büşra Sultan Sevindik, Özlem Olguner Eker, Akif Asdemir, Esra Kısacık, Ayşe Işık, Eser Kılıç, Ertuğrul Eşel

Förderung

  • The Scientific Research Project Unit of Erciyes University

Zitieren

APA

Sevindik, B. S., Olguner Eker, Ö., Asdemir, A., Kısacık, E., Işık, A., Kılıç, E., & Eşel, E. (2026). Serum Galectin‐1 and Galectin‐3 Levels and Their Relationship With Executive Functions and Memory in Patients With Major Depressive Disorder. Human Psychopharmacology: Clinical and Experimental, 41(4). https://doi.org/10.1002/hup.70052

Vancouver

Sevindik BS, Olguner Eker Ö, Asdemir A, Kısacık E, Işık A, Kılıç E, et al. Serum Galectin‐1 and Galectin‐3 Levels and Their Relationship With Executive Functions and Memory in Patients With Major Depressive Disorder. Human Psychopharmacology: Clinical and Experimental. 2026;41(4). doi:10.1002/hup.70052

BibTeX
@article{Sevindik2026,
  author = {Sevindik, Büşra Sultan and Olguner Eker, Özlem and Asdemir, Akif and Kısacık, Esra and Işık, Ayşe and Kılıç, Eser and Eşel, Ertuğrul},
  title = {Serum Galectin‐1 and Galectin‐3 Levels and Their Relationship With Executive Functions and Memory in Patients With Major Depressive Disorder},
  journal = {Human Psychopharmacology: Clinical and Experimental},
  year = {2026},
  volume = {41},
  number = {4},
  doi = {10.1002/hup.70052}
}
Kostenlos starten →